Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: Comparison of bone marrow and peripheral blood progenitor cells

Leukemia and Lymphoma

Volumn 22, Issue 5-6, 1996, Pages 449-456

  Brice, Pauline ^a   Marolleau, Jean Pierre ^a   Pautier, Patricia ^a   Makke, Jaafar ^a   Cazals, Dominique ^a   Dombret, Hervé ^a   D'Agay, Marie Françoise ^a   Benbunan, Marc ^a   Gisselbrecht, Christian ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Bone marrow transplantation; Hematogic recovery; Lymphoma; Peripheral stem cell transplantation

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

EID: 0029797171     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054783     Document Type: Article

References (31)

1. Armitage, J. O. (1989) Bone marrow transplantation in the treatment of patients with lymphoma. Blood, 73, 1749-1758.
2. Philip, T., Armitage, J. O., Spitzer, G. et al. (1987): High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-hodgkin's lymphoma. New England Journal of Medicine, 316, 1493-1498.
3. Bell, A. J., Hamblin, T. J., Oscier, D. G. (1986) Circulating stem cell autografts. Bone Marrow Transplantation, 1, 103-110.
4. Brandt, S. J., Peters, W. D., Atwater, S. K. et al. (1988) Effect of recombinant human GMCSF on hematopoietic reconstitution after high dose chemotherapy and autologous bone marrow transplantation. New England Journal of Medicine, 318, 869-876.
5. Sheridan, W.P., Morstyn, G., Wolf, M. et al. (1989) GCSF and neutrophil recovery after high dose chemotherapy and autologous bone marrow transplantation. Lancet, ii, 891-895.
6. Brice, P., Marolleau, J.P., Dombret, H. et al. (1992) Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. Bone Marrow Transplantation, 9, 337-342.
7. Sheridan, W. P., Begley, C. G., Juttner, C. A. et al. (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640-645.
8. Brice, P., Divine, M., Marolleau, J. P. et al. (1994) Comparison of autografting using mobilized peripheral blood stem cells with and without GCSF in malignant lymphomas. Bone Marrow Transplantation, 14, 51-55.
9. Juttner, C. A., To, B., Ho, J. Q. et al. (1988) Early lymphohemopoietic recovery after autografting using peripheral blood stemcells in acute non lymphoblastic leukemia. Transplantation Proceedings, 20, 40-43.
10. Korbling, M., Holler, Haas, R. et al. (1990) Autologous blood stemcell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. Journal of Clinical Oncology, 8, 978-985.
11. Gribben, J. G., Neuberg, D., Barber, M. et al. (1994) Detection of residual lymphoma cells by PCR in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood, 33, 3800-3807.
12. Shpall, E. J., Jones, R.B., Bearman, S.I. et al. (1994) Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy. Journal of Clinical Oncology, 12, 28-34.
13. Sutherland, H. J., Eaves, C. J., Lansdorp, P. M., Philips, G. L. and Hogge, D. E. (1994) Kinetics of committed and primitive blood, progenitors mobilized after chemotherapy and growth factor treatment and their use in autotransplants. Blood, 83, 3808-3814.
14. Vose, J. M., Anderson, J. R., Kessinger, A. et al. (1993) High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 11, 1846-1851.
15. Thomas, E. D., Storb, R. (1970) Technique for human marrow grafting. Blood, 36, 507-515.
16. Kaplan, E. S. and Meier, P. (1958) Non parametric estimation from incomplete observation observations. Journal of American Statistics Association, 53, 457-461.
17. Gisselbrecht, C., Prentice, H. G., Bacigalupo, A. et al. (1994) Placebo-controlled phase III trial of lenograstim in bone marrow transplantation. Lancet, 343, 696-700.
18. Kessinger, A., Armitage, J.O., Smilh, D.M. et al. (1989) High dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood, 74, 1260-1265.
19. Bastion, Y., Brice, P., Haioun, C. et al. (1995) Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood, 86, 3257-3262.
20. Fermand, J. P., Levy, Y., Gerota, J. et al. (1989) Treatment of aggressive multiple myeloma by high-dose chemotherapy and TBI followed by blood stem cell autologous graft. Blood, 73, 20-23.
21. Hill, D. R., Holladay, M. S., Heslop, H. E. et al. (1993) The contribution of autologous marrow infusion to the restoration of long term hemopoiesis in cancer patients, a study using gene marking. Blood, 82, suppl 1, abstract 331.
22. Brice, P., Godin, S., Libert, O. et al. (1994) Influence du facteur de croissance granulocytaire (GCSF) sur le cout des autogreffes de moelle en hemato-oncologie. La Presse Medicale, 23, 1512-1515.
23. Welch, H. G., Larson, E. B. (1989) Cost effectiveness of bone marrow transplantation in acute non lymphocytic leukemia. New England Journal of Medicine, 321, 807-812.
24. Uchida, N., Murray, L., Altenhofen, J. et al. (1993) Kinetic analysis and isolation of CD34+ THY 1+ LIN- cells from mobilized peripheral blood of multiple myeloma patients. Proceedings of American Society of He matology, 82, suppl. 1, abstract 324.
25. Freedman, A. S., Takvorian, T. Anderson, K. C. et al. (1990) Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. Journal of Clinical Oncology, 8, 784-791.
26. Bosly, A., Coiffier, B., Gisselbrecht, C. et al. (1992) Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH 84 regimen. Journal of Clinical Oncology, 10, 1615-1623.
27. Chopra, R., McMillan, A. K., Linch, D. C. et al. (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor risk Hodgkin's disease, a single center eight year study of 155 patients. Blood, 81, 1137-1145.
28. Baro, J., Richard, C., Calavia, J. et al. (1991) Autologous bone marrow transplantation as consolidation therapy for non Hodgkin's lymphoma patients with poor prognostic features. Bone Marrow Transplantation, 8, 283-289.
29. Jagannath, S., Armitage, J. O., Dicke, K. A. et al. (1989) Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine and etoposide with ABMT for relapsed Hodgkin's disease. Journal of Clinical Oncology, 7, 179-185.
30. Crump, M., Smith, A. M., Brandwein, J. et al. (1993) High dose etoposide and melphalan and ABMT for patients with advanced Hodgkin's disease: importance of disease status at transplant. Journal of Clinical Oncology, 11, 704-711.
31. Freedman, A. S., Ritz, J., Neuberg, D. et al. (1991) ABMTin 69 patients with a history of low grade B-cell non-Hodgkin's lymphoma. Blood, 77, 2524-2529.